Nasdaq · Healthcare
Alphatec Holdings, Inc. (ATEC)
As-reported financials and recent SEC filings for Alphatec Holdings, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$764.2M
Net income
$-143.4M
Net margin
-18.8%
Diluted EPS
$-0.96
ROE
-1153.7%
P/E (TTM)
—
Market cap
$1.43B
Debt / equity
40.4×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $764.2M | $611.6M | $482.3M | $350.9M | $243.2M |
| Gross profit | $531.9M | $424.3M | $310.2M | $233.1M | $157.8M |
| Operating income | $-82.1M | $-136.2M | $-173.4M | $-147.0M | $-128.1M |
| Net income | $-143.4M | $-162.1M | $-186.6M | $-151.3M | $-143.0M |
| Diluted EPS | $-0.96 | $-1.13 | $-1.54 | $-1.46 | $-1.49 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →1442026-06-11
View on EDGAR →S-82026-06-11
View on EDGAR →Go deeper on ATEC
Search Alphatec Holdings, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.